Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Teladoc stock jumps on GLP-1 deal with Eli Lilly

In This Article:

Teladoc (TDOC) shares are climbing on Thursday after the healthcare company announced its deal with Eli Lilly's (LLY) direct-to-consumer pharmacy partner Lilly Direct. The deal is set to streamline consumer access to the weight loss drug Zepbound.

Market Domination hosts Josh Lipton and Julie Hyman outline the details.

To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

This post was written by Sydney Strauss